Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F91UN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $143,617
Award facts
- Contract value 100% obligated
- $143,617.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $143,617.01 to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL configuration. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of December 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Cosentyx is a biologic immunosuppressant used for treating autoimmune conditions, and its procurement through the DLA supply chain ensures availability for military beneficiaries and healthcare systems. AmerisourceBergen's consistent receipt of competitively awarded delivery orders reflects its established capability to meet federal pharmaceutical procurement requirements and support the Defense Health Agency and other government healthcare customers.
Quick answers
Who was awarded contract SPE2DR26F91UN?
SPE2DR26F91UN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F91UN worth?
The government has obligated $143,617 on SPE2DR26F91UN.
Is contract SPE2DR26F91UN an order under another contract?
Yes. SPE2DR26F91UN is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F91UN competed?
The extent of competition for SPE2DR26F91UN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award